N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
about
N-acetylcysteine -- passe-partout or much ado about nothing?Mitochondria: a new therapeutic target in chronic kidney diseaseN-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review protocolLiposomal Antioxidants for Protection against Oxidant-Induced DamageN-acetylcysteine for the prevention of non-contrast media agent-induced kidney injury: from preclinical data to clinical evidence.A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.N-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis.Prevention of contrast-induced nephropathy: A randomized controlled trial of sodium bicarbonate and N-acetylcysteineIdentification of agents that reduce renal hypoxia-reoxygenation injury using cell-based screening: purine nucleosides are alternative energy sources in LLC-PK1 cells during hypoxiaRenal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy.Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention.[Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial].Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography.Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategiesN-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?Evaluation of the protective effect of N-acetylcysteine on contrast media nephropathyClinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist.Hydrogen peroxide and central redox theory for aerobic life: A tribute to Helmut Sies: Scout, trailblazer, and redox pioneerN-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review.Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled TrialN-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models.A Systems Approach Implicates a Brain Mitochondrial Oxidative Homeostasis Co-expression Network in Genetic Vulnerability to Alcohol Withdrawal.Pharmacological strategies to prevent contrast-induced acute kidney injury.Nephrotoxicity of contrast media and protective effects of acetylcysteine.Intravenous N-acetylcysteine in the prevention of contrast media-induced nephropathy.Effect of preoperative N-acetylcysteine on postoperative blood loss parameters in cardiac surgery patientsPrevention of contrast-induced nephropathy in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review.Incidence and risk factors of contrast-induced nephropathy after bronchial arteriography or bronchial artery embolization.N-Acetylcysteine supplementation alleviates intestinal injury in piglets infected by porcine epidemic diarrhea virus.Induction of metallothionein in proximal tubular cells by zinc and its potential as an endogenous antioxidant.Efficacy of Atorvastatin in Prevention of Contrast-induced Nephropathy in High-risk Patients Undergoing Angiography: A Double-blind Randomized Controlled Trial.Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency.Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender DifferencesPreventing contrast nephropathy in catheter laboratory.N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration.Ioxitalamate induces renal tubular apoptosis via activation of renal efferent nerve-mediated adrenergic signaling, renin activity, and reactive oxygen species production in rats.Prolonged carotid sinus reflex is a risk factor for contrast-induced nephropathy following carotid artery stenting.Prophylactic effect of liposomal N-acetylcysteine against LPS-induced liver injuries.Therapeutic effect of liposomal-N-acetylcysteine against acetaminophen-induced hepatotoxicity.
P2860
Q24678741-980AA395-D02F-47E2-8FCA-FBCC337318C3Q26776397-9D02A440-C90E-4AA2-96AD-B6B77BFA80EBQ27014948-C7ED4813-7095-42B1-8F41-8F5FCD1104F2Q28391211-A4AD7621-F093-4CA2-81FA-65DE61A2DA01Q30603357-24EEB7B4-EA21-4657-9712-938A4DA7A6DFQ33305487-7BE5A33B-4643-4CA3-9146-9A7A4098CC71Q33555008-1FB8FBD7-9C9A-403C-8829-699433123E7AQ33989419-8987F072-ABE3-4A8F-8749-35FE7E29B49AQ34078831-2D762238-1BEA-42CE-9288-2A88A2D940EEQ34106037-3BB9BFD2-7E32-44E0-8B4E-E87C2FC384CDQ34467009-FA727361-BD6E-4E2F-BE55-C6607F56E8B2Q35472514-BE29970A-6149-40CB-B90F-B4B9D5236250Q35999430-C1D6EEA0-AFA4-4C20-925C-8843B752812BQ36136330-C9C9EFD9-2920-4A9D-9F5F-0E636EEEDA68Q36277926-EC95A98A-A9D8-40ED-8A8B-4D2121D4D119Q36389997-2205BA4E-7311-4257-912D-5F7ADAEF6F10Q36513004-FFE5C26C-1149-476B-B1B1-DDB0F055CB40Q36819324-B2E4790E-006C-4861-847C-CC99A0CD32B4Q36924709-04631716-548A-4B7F-9E8F-ECFBFFE6667AQ37090807-1C0A24C9-2C53-4DE3-A916-4E295BA900FCQ37271293-DA68A24C-9C8E-4A4B-8D2F-D5C3F8725C74Q37418479-B1EBD018-8867-4038-9ED6-82B6ECE61606Q37550746-E0A645B9-2497-4F97-B164-97B355C5C8D1Q37639849-18A6D9EB-F2FC-4013-8621-D5340226B67AQ37817813-5D0C9A29-E2F7-48DC-B7A4-659BB851C02AQ37826019-BA011764-FBD6-438A-B84E-C6F57B532659Q37901398-2350695C-38B8-4CCC-A4A3-040D3799B80FQ38067457-22D0972E-F4BB-4336-8CD0-F004F56C551AQ38450387-F8FC6325-2E15-41B9-BAA1-B5CEC2C3864EQ40309100-7DB66110-CE53-4701-9DA2-94A2795371D2Q40438531-FE79A106-83F6-4A89-BE14-6B50685515C7Q40963091-708D9AD4-64D6-412F-9504-251A7F89C3CAQ42281143-37F5236C-AAFB-45C4-8229-F9BFEA9E176EQ42343539-A85402A4-6397-43D4-91FA-BB584AF4C6DEQ42409825-818C8761-D7D0-4C32-A1B9-BF6D2CEAAAECQ43012450-E8ABE700-E97E-4409-BA18-11733F855A44Q43234068-C122F086-9139-4BE5-9D1D-A6FAFF9FB91FQ44825251-4497CE1E-B243-40E2-A37E-B3B89E3F1098Q44872015-6E96DE90-7147-4455-B9AE-5DE86ED61E75Q44947668-70CFDD50-7D98-427F-B4E2-3C63DA38FE57
P2860
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
@ast
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
@en
type
label
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
@ast
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
@en
prefLabel
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
@ast
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
@en
P2093
P1476
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
@en
P2093
John H Durham
Kevin Marzo
Michael Rudnick
Steven Fishbane
P304
P356
10.1097/01.ASN.0000107562.68920.92
P577
2004-02-01T00:00:00Z